Open AccessHybrid Therapy Regimen for Helicobacter Pylori Eradication
Author(s) -
Zhiqiang Song,
Jian Liu,
Liya Zhou
Publication year - 2016
Publication title -
chinese medical journal/chinese medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 63
eISSN - 2542-5641
pISSN - 0366-6999
DOI - 10.4103/0366-6999.179803
Subject(s) - clarithromycin , medicine , helicobacter pylori , metronidazole , regimen , adverse effect , antibiotic resistance , antibiotics , intensive care medicine , gastroenterology , microbiology and biotechnology , biology
Helicobacter pylori (H. pylori) eradication remains a challenge with increasing antibiotic resistance. Hybrid therapy has attracted widespread attention because of initial report with good efficacy and safety. However, many issues on hybrid therapy are still unclear such as the eradication efficacy, safety, compliance, influencing factors, correlation with antibiotic resistance, and comparison with other regimens. Therefore, a comprehensive review on the evidence of hybrid therapy for H. pylori infection was conducted.